In addition, Casp8ΔE385/ΔE385Ripk3−/− and Casp8ΔE385/ΔE385Mlkl−/− mice develop severe lymphopenia that can be prevented by reducing the RIPK1 dosage by half, not by RIPK1 kinase inactive mutant. Here, RIPK1 is linked to lymphopenia.